Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

J. Jill, Inc. Common Stock (NY:JILL)

16.04 -0.12 (-0.74%)
Official Closing Price Updated: 6:30 PM EDT, Oct 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about J. Jill, Inc. Common Stock

< Previous 1 2 3 4 5 Next >
Demystifying J.Jill: Insights From 6 Analyst Reviews
 
Via Benzinga
J.Jill (JILL) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings World Trade
5 Analysts Assess J.Jill: What You Need To Know
 
Via Benzinga
J.Jill Reports Q2 Sales of $154 Million
Via The Motley Fool
Topics Economy World Trade
J.Jill Reports 23% Profit Drop in Q2
Via The Motley Fool
Topics Economy Supply Chain World Trade
A Look Ahead: J.Jill's Earnings Forecast
 
Via Benzinga
Earnings Preview: J.Jill
 
Via Benzinga
A Glimpse Into The Expert Outlook On J.Jill Through 5 Analysts
 
Via Benzinga
J.Jill Analysts Slash Their Forecasts After Q2 Earnings Results
 
Via Benzinga
Earnings Scheduled For September 3, 2025
 
Via Benzinga
DoorDash To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Thursday
 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
What 5 Analyst Ratings Have To Say About J.Jill
 
Via Benzinga
What 4 Analyst Ratings Have To Say About J.Jill
 
Via Benzinga
How Is The Market Feeling About J.Jill?
 
Via Benzinga
J.Jill (JILL) Q1 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings Economy
J.Jill Stock Slides After Q1 Revenue Miss, Margin Pressure, And FY25 Guidance Withdrawal
J.Jill shares tumble after Q1 revenue miss, margin decline, and FY25 guidance withdrawal amid macro uncertainty and leadership changes. 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Earnings Scheduled For June 11, 2025
 
Via Benzinga
How To Earn $500 A Month From J.Jill Stock Ahead Of Q1 Earnings
J.Jill offers an annual dividend yield of 1.87%. Here's how to earn $500 monthly from J.Jill, we start with the yearly target of $6,000. 
Via Benzinga
Top 3 Consumer Stocks That May Rocket Higher This Quarter
 
Via Benzinga
Earnings Scheduled For March 19, 2025
 
Via Benzinga
J.Jill Exceeds Q2 Expectations, Lowers 2024 Guidance Due To Changing Consumer Behavior
J. Jill Inc reported Q2 2024 sales of $155.242M, down 0.9% YoY but beating estimates. Comparable sales up 1.7%. Adjusted EPS of $1.05 also beat consensus. Q3 sales expected to decline while 2024... 
Via Benzinga
Retailer Caleres Stock Scores RS Rating Upgrade
Caleres stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an increase from 70 to 76. 
Via Investor's Business Daily
American Eagle Outfitters Stock Popped 10% This Month, Getting Ready To Soar?
AEO stock is up about 10% in the last three weeks and has closed higher five of the last eight trading sessions. 
Via Investor's Business Daily
This Spotify Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
 
Via Benzinga
Bull Of The Day: J. Jill
J.Jill is a national women's retailer that provides apparel, footwear and accessories. It operates 244 stores in the United States and an e-commerce platform. It's a small cap company with a market cap... 
Via Talk Markets
Foot Locker Stock Earns Relative Strength Rating Upgrade
In a welcome move, Foot Locker stock saw its Relative Strength (RS) Rating improve from 70 to 74 on Thursday. 
Via Investor's Business Daily
S&P 500 Edges Higher; J.Jill Shares Plunge
 
Via Benzinga
Topics Stocks
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.